{
"id":"mk19_qq_q067",
"number":67,
"bookId":"qq",
"correctAnswer":"D",
"title":"Question 67",
"stimulus":[
{
"type":"p",
"hlId":"066f26",
"children":[
"A 78-year-old man was admitted to the ICU 3 days ago for gram-negative urosepsis. He was treated with antibiotics, fluid resuscitation, and vasopressors. He is now hemodynamically stable with no evidence of bleeding. Vasopressor treatment has been discontinued."
]
},
{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"lab-values table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"a462a3",
"children":[
"Laboratory studies:"
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"d41d8c",
"class":"cell text l",
"children":[

]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"222a26",
"class":"cell text l",
"children":[
"Current"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"d41d8c",
"class":"cell text l",
"children":[

]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"3d9fad",
"class":"cell text l",
"children":[
"At Admission"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"d41d8c",
"class":"cell text l",
"children":[

]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"f9867c",
"class":"cell text l",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Hemoglobin, blood",
"children":[
"Hemoglobin"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"e5db40",
"class":"cell text l",
"children":[
"7.7 g/dL (77 g/L)"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"d20cae",
"class":"cell text l",
"children":[
"L"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"72dd08",
"class":"cell text l",
"children":[
"10.6 g/dL (106 g/L)"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"d20cae",
"class":"cell text l",
"children":[
"L"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"f461b2",
"class":"cell text l",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Creatinine, serum",
"children":[
"Creatinine"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"c5718b",
"class":"cell text l",
"children":[
"2.1 mg/dL (185.6 µmol/L)"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"c1d9f5",
"class":"cell text l",
"children":[
"H"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"5348b7",
"class":"cell text l",
"children":[
"4.5 mg/dL (397.8 µmol/L)"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"c1d9f5",
"class":"cell text l",
"children":[
"H"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"7450c0",
"class":"cell text l",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Iron studies, Iron, serum",
"children":[
"Iron studies"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"d41d8c",
"class":"cell text l",
"children":[

]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"d41d8c",
"class":"cell text l",
"children":[

]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"d41d8c",
"class":"cell text l",
"children":[

]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"d41d8c",
"class":"cell text l",
"children":[

]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft2"
},
"children":[
{
"type":"p",
"hlId":"a5c037",
"class":"cell text li",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Iron studies, Ferritin, serum",
"children":[
"Ferritin"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"b93cf9",
"class":"cell text l",
"children":[
"410 ng/mL (410 µg/L)"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"c1d9f5",
"class":"cell text l",
"children":[
"H"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"37ce74",
"class":"cell text l",
"children":[
"–"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"d41d8c",
"class":"cell text l",
"children":[

]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft2"
},
"children":[
{
"type":"p",
"hlId":"1f3a27",
"class":"cell text li",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Iron studies, Iron, serum",
"children":[
"Iron"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"26430b",
"class":"cell text l",
"children":[
"30 µg/dL (5.4 µmol/L)"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"d20cae",
"class":"cell text l",
"children":[
"L"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"37ce74",
"class":"cell text l",
"children":[
"–"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"d41d8c",
"class":"cell text l",
"children":[

]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft2"
},
"children":[
{
"type":"p",
"hlId":"181011",
"class":"cell text li",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Iron studies, Iron-binding capacity (TIBC), total, serum",
"children":[
"Total iron-binding capacity"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"6d2623",
"class":"cell text l",
"children":[
"144 µg/dL (25.8 µmol/L)"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"d20cae",
"class":"cell text l",
"children":[
"L"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"37ce74",
"class":"cell text l",
"children":[
"–"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"d41d8c",
"class":"cell text l",
"children":[

]
}
]
}
]
}
]
}
]
}
],
"prompt":[
" ",
{
"type":"p",
"hlId":"5fe263",
"children":[
"Which of the following is the most appropriate treatment for this patient's anemia?"
]
},
" "
],
"options":[
{
"letter":"A",
"text":{
"__html":"Epoetin alfa"
}
},
{
"letter":"B",
"text":{
"__html":"Intravenous iron dextran"
}
},
{
"letter":"C",
"text":{
"__html":"Transfusion of 2 units of packed red blood cells"
}
},
{
"letter":"D",
"text":{
"__html":"No change in treatment"
}
}
],
"keypoints":[
{
"type":"keypoint",
"hlId":"9b10bb",
"children":[
"A restrictive transfusion threshold (hemoglobin level <7-8 g/dL [70-80 g/L]) is recommended in common clinical settings in which blood is transfused, such as in critically ill patients in the ICU."
]
},
{
"type":"keypoint",
"hlId":"603d04",
"children":[
"The restrictive transfusion threshold (hemoglobin level <7-8 g/dL [70-80 g/L]) does not apply to patients who are hemodynamically unstable or actively bleeding and should not be applied to symptomatic patients with rapidly decreasing hemoglobin concentrations."
]
}
],
"exposition":[
{
"type":"p",
"hlId":"de3a4b",
"children":[
"No change in treatment (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option D"
]
},
"), including transfusion, is necessary for this patient. In a randomized phase III study of euvolemic patients whose hemoglobin level decreased to less than 9 g/dL (90 g/L) within 72 hours of ICU admission, participants were assigned to a liberal transfusion group (transfusion given at hemoglobin level <10 g/dL [100 g/L]) or a restrictive transfusion group (transfusion given at hemoglobin level <7 g/dL [70 g/L]). Mortality rates were at least as good for patients in the restrictive group as for those in the liberal group. However, a subset analysis revealed that patients with ischemic heart disease had a trend toward higher mortality in the restrictive group that was not statistically significant, which suggests that patients with ischemic heart disease should be evaluated on a case-by-case basis until further data dictate otherwise. The restrictive transfusion threshold does not apply to patients who are hemodynamically unstable or actively bleeding and should not be applied to symptomatic patients with rapidly decreasing hemoglobin concentrations."
]
},
{
"type":"p",
"hlId":"d7f7ad",
"children":[
"Although this patient has an elevated creatinine level, it is likely the result of sepsis and seems to be improving. As such, there is no role for an erythropoiesis-stimulating agent (ESA), such as epoetin alfa (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option A"
]
},
"). Furthermore, ESAs have not been studied for this indication."
]
},
{
"type":"p",
"hlId":"6d6f75",
"children":[
"This patient has iron indices typical of anemia of inflammation (low serum iron level, low total iron-binding capacity [TIBC], low transferrin saturation [<15%; iron/total iron-binding capacity × 100], and elevated ferritin level) that are most likely the result of sepsis and not iron deficiency anemia (low serum iron level, high-normal to high TIBC, high transferrin saturation, and low ferritin level). Therefore, intravenous iron dextran (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option B"
]
},
") is not indicated. Iron dextran was the principal intravenous iron product used in the past, but because of its risk for anaphylaxis and relatively poor bioavailability, newer parenteral iron preparations with a better safety profile and better ferrokinetics are used more often. These agents include iron sucrose, ferric gluconate, ferumoxytol, and ferric carboxymaltose. Data are inadequate to recommend one newer parenteral agent over another for patients requiring parenteral iron."
]
},
{
"type":"p",
"hlId":"bb9bd7",
"children":[
"The Association for the Advancement of Blood & Biotherapies recommends a restrictive erythrocyte transfusion threshold in hemodynamically stable critical care patients; erythrocyte transfusion (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option C"
]
},
") should not be performed until the hemoglobin level is 7 g/dL (70 g/L) or lower. The guideline concludes that no data suggest that a restrictive approach is harmful and that a restrictive threshold is associated with reduced blood use and related costs, as well as fewer potentially serious, although uncommon, adverse events."
]
}
],
"relatedSection":"mk19_b_hm_s8_3",
"objective":{
"__html":"Manage anemia in a critically ill hospitalized patient."
},
"references":[
[
"Carson JL, Guyatt G, Heddle NM, et al. Clinical practice guidelines from the AABB: red blood cell transfusion thresholds and storage. JAMA. 2016;316:2025-2035. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/27732721",
"target":"_blank"
},
"children":[
"PMID: 27732721"
]
},
" doi:10.1001/jama.2016.9185"
]
],
"hospitalist":true,
"hvc":false,
"peerComparison":{
},
"hlIds":[
"066f26",
"a462a3",
"d41d8c",
"222a26",
"d41d8c",
"3d9fad",
"d41d8c",
"f9867c",
"e5db40",
"d20cae",
"72dd08",
"d20cae",
"f461b2",
"c5718b",
"c1d9f5",
"5348b7",
"c1d9f5",
"7450c0",
"d41d8c",
"d41d8c",
"d41d8c",
"d41d8c",
"a5c037",
"b93cf9",
"c1d9f5",
"37ce74",
"d41d8c",
"1f3a27",
"26430b",
"d20cae",
"37ce74",
"d41d8c",
"181011",
"6d2623",
"d20cae",
"37ce74",
"d41d8c",
"5fe263",
"9b10bb",
"603d04",
"de3a4b",
"d7f7ad",
"6d6f75",
"bb9bd7"
]
}